MedPath

A clinical study to check intensive hair repair masque in healthy volunteers for its safety and efficacy.

Phase 4
Registration Number
CTRI/2022/03/041070
Lead Sponsor
Mountain Valley Springs India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Healthy subjects (no infectious and evaluative pathology which could make the

subject vulnerable and stop the study, no pathology which could interfere with the

study, no symptom in the process of an exploratory check-up)

Indian Male/Female subjects.

Hair & scalp is healthy on the studied anatomic unit (free of eczema, wounds,

inflammatory scar etc)

Between 18 to 65 years of age, with normal Hair condition.

Written informed consent signed by the subject in line with applicable regulation

of country.

Exclusion Criteria

Having refused to give her consent by not signing the consent form.

Taking part in another study liable to interfere with this study.

Having a chronic dermatosis liable to modify the cutaneous reactivity on the

tested area (except for specific studies on a determined dermatosis).

Having a diagnosed or highly probable allergy to one or several compounds of

the cosmetic products or food products.

Having cutaneous hypersensitivity.

Having applied a cosmetic product (included make-up) on the studied areas the

first day of the study (only hair & scalp cleaned with water is accepted).

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation will include assessment of local adverse events of redness, itching, rashes and burning sensations and any other local side effect and will be categorized non serious (based on severity grades, patterns, and causality) and serious adverse events. There will be two types of assessment, subject self-assessment, and dermatological evaluation by study investigatorTimepoint: Subject will be assesed at 30 minutes, 15 days and 30 days of first application
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath